KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

LifeMD (LFMD) Other Non-Current Assets (2017 - 2024)

LifeMD filings provide 5 years of Other Non-Current Assets readings, the most recent being $6.7 million for Q4 2024.

On a quarterly basis, Other Non-Current Assets changed N/A to $6.7 million in Q4 2024 year-over-year; TTM through Dec 2024 was $6.7 million, a N/A change, with the full-year FY2024 number at $6.7 million, changed N/A from a year prior.
Other Non-Current Assets hit $6.7 million in Q4 2024 for LifeMD, up from $1.1 million in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $6.7 million in Q4 2024 to a low of $60832.0 in Q1 2020.